The efficacy of anlotinib instead of glucocorticoids for edema induced by brain metastases in NSCLC patients with anti-PD1/PDL-1 immunotherapy

Neuro Oncol. 2021 Jan 30;23(1):169-171. doi: 10.1093/neuonc/noaa236.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Brain Neoplasms* / drug therapy
  • Edema
  • Glucocorticoids
  • Humans
  • Immunotherapy
  • Indoles
  • Lung Neoplasms* / drug therapy
  • Quinolines

Substances

  • Glucocorticoids
  • Indoles
  • Quinolines
  • anlotinib

Associated data

  • ChiCTR/ChiCTR1800017929
  • ClinicalTrials.gov/NCT04147728